Xiuying Li

Xiuying Li is a seasoned scientist with extensive experience in the fields of non-viral gene delivery and nanoformulation. Currently serving as a Senior Scientist at Life Edit Therapeutics since April 2023, Xiuying focuses on novel lipid nanoparticle (LNP) discovery and process development. Prior to this, Xiuying worked at IMMORNA, where responsibilities included the design and development of various nanoformulations for mRNA delivery. Experience also includes a role as Formulation Scientist II at Nexus Pharmaceuticals, where Xiuying developed complex injectable drug products and supported ANDA submissions. At The University of Texas at Dallas, Xiuying held positions as a Research Scientist and Research Associate, where significant contributions included the invention of a smart photo-mechanic sensitive vesicle and the development of advanced drug release techniques. Educational qualifications include a PhD in Pharmaceutical Sciences from the Shanghai Institute of Materia Medica and a visiting PhD student position at Novo Nordisk A/S and Copenhagen University.